公开(公告)号：US20190211360A1

公开(公告)日：2019-07-11

申请号：US16356005

申请日：2019-03-18

Applicant: GENETHON

Inventor： NICOLAS MARCEAU ,  MEHDI GASMI

IPC: C12N15/86 ,  C12N7/00 ,  C12N7/02

CPC classification number: C12N15/86 ,  C12N7/00 ,  C12N7/02 ,  C12N2740/10051 ,  C12N2740/15011 ,  C12N2740/16051

Abstract: The present invention relates to the industrialization of the production of recombinant lentiviral vectors in order to manufacture sufficient materials for therapeutic applications such as gene therapy and/or DNA vaccination, for use in clinical trials and/or commercial use.

公开(公告)号：US20220235371A1

公开(公告)日：2022-07-28

申请号：US17464727

申请日：2021-09-02

Applicant: GENETHON

Inventor： NICOLAS MARCEAU ,  MEHDI GASMI

IPC: C12N15/86 ,  C12N7/02 ,  C12N7/00

Abstract: The present invention relates to the industrialization of the production of recombinant lentiviral vectors in order to manufacture sufficient materials for therapeutic applications such as gene therapy and/or DNA vaccination, for use in clinical trials and/or commercial use.